LEMD1-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LEMD1-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LEMD1-AS1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LEMD1-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LEMD1-AS1 expression acts as an unfavorable survival marker, although some lineages such as OV and HNSC show a favorable association.

OV, KIRP, and HNSC are the cancer types where LEMD1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
OVOSQuartileII,III,IV0.8960.759<.001104view →
KIRPDFSQuartileII,III,IV0.3190.806<.00173view →
HNSCDFSQuartileAll0.7770.647.00469view →
LGGOSMedianAll0.3550.531<.00154view →
DLBCOSMedianAll0.4730.960.00244view →
KIRCDFSQuartileII,III,IV0.2970.621<.00138view →
READDFSMedianAll0.7230.893.00136view →
ESCAOSQuartileIII,IV0.8310.223<.00133view →
LIHCDFSTertileII,III,IV0.4390.171.00731view →
COADDFSMedianAll0.3940.615.00129view →
STADDFSMedianIII,IV0.6760.504.00227view →
BLCADFSTertileIV0.3080.611.02021view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

Exploration